Divalproex Sodium Tablet, Extended Release
Product Images NDC 72789-286

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 72789-286). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

72789286 Label (72789286)

This is a medication label for Divalproex. It advises to avoid alcohol and using caution while driving as the medication causes drowsiness. It also warns not to crush or chew the tablets and to keep the medication out of reach of children. The medication is available in 250 mg film-coated extended-release tablets. Dosage instructions and information about potential side effects are also provided.*

FDA Label Image

Image 1 (D95f9b1b F1e4 4ae4 A215 7317fb1ca565 01)

FDA Label Image

Image 2 (D95f9b1b F1e4 4ae4 A215 7317fb1ca565 02)

The text describes a graph that shows the percentage reduction in CPS rate for patients who were given Divalproex Sodium Delayed-Release compared to those who were given a placebo. The graph also shows the percentage of patients experiencing improvement, no change, or worsening of their condition.*

FDA Label Image

Image 3 (D95f9b1b F1e4 4ae4 A215 7317fb1ca565 03)

FDA Label Image

Image 4 (D95f9b1b F1e4 4ae4 A215 7317fb1ca565 04)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.